Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis - a Double-blind Randomized Controlled Trial

NCT05202860 is registered in ClinicalTrials.gov with Merete Haedersdal as lead sponsor.

NCT NCT05202860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05202860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis - a Double-blind Randomized Controlled Trial
Lead sponsor
Merete Haedersdal
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 9, 2022
Completion date
June 19, 2034
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, basal cell carcinoma, squamous cell carcinoma